Immunophilin ligands as a novel treatment for neurological disorders
- 1 January 2000
- journal article
- research article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 21 (1) , 3-5
- https://doi.org/10.1016/s0165-6147(99)01407-8
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- The immunophilin ligand FK506, but not GPI-1046, protects against neuronal death and inhibits c-Jun expression in the substantia nigra pars compacta following transection of the rat medial forebrain bundleNeuroscience, 1999
- CD95 Ligand (Fas-L/APO-1L) and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Mediate Ischemia-Induced Apoptosis in NeuronsJournal of Neuroscience, 1999
- FK506 increases the regeneration of spinal cord axons in a predegenerated peripheral nerve autograft.The Journal of Spinal Cord Medicine, 1999
- Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal modelsProceedings of the National Academy of Sciences, 1997
- Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemiaNature, 1994
- Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteinsNature, 1989